TLDR
- ARK Invest added $1.7 million in ARK 21Shares Bitcoin ETF positions across two funds on December 9, 2025
- ARKF purchased 5,754 ARKB shares while ARKW bought 49,246 shares at a price of $30.92 each
- The firm sold stakes in Ibotta, Iridium Communications, Adaptive Biotechnologies, and Teradyne
- CFTC introduced framework allowing approved institutions to use cryptocurrencies and stablecoins as margin
- Bitcoin continues experiencing volatility with early U.S. trading frequently erasing overnight price gains
Cathie Wood’s ARK Invest made strategic portfolio changes on December 9, 2025, increasing cryptocurrency exposure while scaling back positions in technology and healthcare companies. The moves came during a volatile period for digital asset markets.
The ARK Fintech Innovation ETF purchased 5,754 shares of the ARK 21Shares Bitcoin ETF. The ARK Next Generation Internet ETF acquired 49,246 shares of the same fund. Combined, these purchases totaled approximately $1.7 million based on ARKB’s $30.92 closing price.

The timing of these buys coincides with turbulent conditions in cryptocurrency markets. Bitcoin has struggled to maintain price stability during U.S. trading hours. Overnight gains have frequently vanished by the time American markets open for business.
Despite volatility, several factors continue supporting cryptocurrency market sentiment. Investors anticipate future Federal Reserve interest rate cuts. Regulatory frameworks for digital assets have become clearer over recent months.
New CFTC Rules Expand Crypto Use in Traditional Finance
The Commodity Futures Trading Commission announced a framework that changes how institutions can use digital assets. Approved firms may now post major cryptocurrencies and stablecoins as margin collateral. Previously, only traditional assets like cash and government securities served this purpose.
This regulatory development strengthens the connection between cryptocurrency markets and conventional financial systems. Institutions can now integrate digital assets into their treasury operations and risk management strategies. The framework provides legal clarity that many financial firms required before expanding crypto operations.
ARK Reduces Positions Across Technology and Life Sciences
While increasing Bitcoin exposure, ARK Invest trimmed multiple equity positions. The firm sold shares of Ibotta, a company that provides digital coupon and cashback services. ARKF disposed of 52,047 shares and ARKW sold 47,141 shares of the company.
Iridium Communications experienced further reductions from ARK portfolios. The satellite services provider saw 23,994 shares sold from the ARK Innovation ETF. This sale continues a trend of decreasing exposure to the communications firm.
The ARK Genomic Revolution ETF made its largest sale by exiting 90,807 shares of Adaptive Biotechnologies. This complete divestment removed the immune medicine company from the genomics fund. ARKG has been adjusting its biotechnology holdings throughout recent months.
The ARK Autonomous Technology & Robotics ETF reduced its position in Teradyne by 2,253 shares. The semiconductor testing equipment manufacturer represents exposure to the chip industry’s infrastructure layer.
Market Conditions Drive Portfolio Adjustments
These trades reflect Wood’s assessment of current market dynamics. Growth stocks face pressure from interest rate uncertainty and economic concerns. Cryptocurrency markets navigate regulatory changes while experiencing price swings.
ARK’s decision to increase Bitcoin ETF holdings shows confidence in digital asset fundamentals despite short-term volatility. The CFTC framework announcement arrived as institutions seek regulated pathways for cryptocurrency investment. ETF structures provide exposure without direct custody requirements that complicate corporate treasury management.
The sales of technology and biotech stocks freed capital for redeployment. ARK shifted resources toward Bitcoin exposure through the regulated ETF wrapper that institutional investors prefer.


